🚀 The Startup Khan Newsletter
Today’s big picture: Firmus abandons a major AI infrastructure IPO, quantum startup Oratomic reaches a $5.4B valuation, and defence AI attracts fresh funding. Capital is still flowing—but execution matters more than ever.
🧠 Top Story: Firmus Cancels Its $5B IPO
Australia’s Nvidia-backed Firmus Technologies has shelved its planned $5 billion IPO, which targeted a valuation of approximately $30.6 billion.
The company will instead explore private financing and alternative international listings.
What happened?
Investors reportedly questioned:
- Ambitious data-centre expansion plans
- Substantial debt and financing requirements
- Limited operating history
- Uncertainty around future infrastructure capacity
Firmus operates two leased data centres and plans five additional facilities.
Investors were being asked to value infrastructure that largely remains to be built.
Why founders should care
The AI infrastructure investment thesis is changing.
Old question:
How much compute capacity can you build?
New question:
How much profitable demand can that capacity reliably serve?
That puts greater emphasis on customer contracts, utilization, construction execution and financing costs.
👉 Founder takeaway: A massive market opportunity doesn’t automatically justify a massive valuation.
Investors increasingly want evidence that ambitious plans can become sustainable revenue.
💰 Funding Watch: Oratomic Reaches $5.4B
Quantum computing startup Oratomic has raised $475 million in Series B funding, reaching a reported $5.4 billion valuation.
The company has secured approximately $775 million since launching in March 2026.
Its technology uses neutral atoms and advanced error correction to develop fault-tolerant quantum computers.
Investors include ARCH Venture Partners, Spark Capital, Khosla Ventures, Index Ventures and General Catalyst.
The founder lesson
Frontier technology can attract enormous capital before commercialization.
But two milestones matter:
Technical breakthrough → Commercial usefulness
They’re not the same thing.
👉 Founder takeaway: Demonstrate scientific progress, but build a credible path toward customer value.
🛡️ Defence AI: Gallatin Raises $50M
Gallatin AI has raised a $50 million Series A, bringing total funding to $70 million.
Its Navigator platform helps military organizations forecast supply requirements, manage logistics and improve operational planning.
The company says its technology is already deployed with U.S. military units.
The broader opportunity extends beyond defence.
Complex logistics also exist in:
Manufacturing → Construction → Transportation → Industrial supply chains
👉 Founder signal: Some of AI’s strongest opportunities are hidden inside expensive, fragmented operational workflows.
🧬 IPO Watch: Iambic Targets $159M
AI drug-discovery company Iambic Therapeutics is seeking up to $159.4 million in a proposed U.S. IPO.
The offering could value the company at approximately $806 million.
Iambic uses AI to support drug discovery and is developing treatments for solid tumours.
The IPO has not yet been completed.
The lesson is straightforward:
In biotechnology, AI capabilities matter—but successful clinical development ultimately determines commercial value.
🔴 Founder Opportunity Radar
🇨🇦 October 12 — Startup in Residence
Canadian startups can apply for a CAD $15,000 grant, expert support and potential investment of up to CAD $250,000, subject to eligibility.
Deadline: 11:59 p.m. ET.
🐾 October 18 — Leap Venture Studio
Pet-care accelerator offering selected startups a 12-week program and a $200,000 investment, subject to program terms.
🚀 November 18 — Techstars 2027
Applications remain open for multiple accelerator programs, including London, Boston, Chicago and New York City.
⚡ Founder Framework: The Capital Efficiency Test
Before your next raise, answer three questions.
CAPITAL
How much funding do you actually need to reach the next meaningful milestone?
EVIDENCE
What measurable proof will justify your next valuation?
RISK
Which assumptions could prevent you from reaching that milestone?
The goal isn’t simply to raise more money.
It’s to use capital to reduce uncertainty and increase business value.
Quick win: Identify the single milestone that would most improve your fundraising position. Build your next financing plan around achieving it.
🧩 Final Thought
Today’s stories reveal two realities.
Private investors still have enormous appetite for frontier technology.
But public-market investors are asking harder questions about execution, valuation and financial sustainability.
For founders, the lesson is simple:
A big valuation gets attention.
Real execution earns confidence.
The strongest startups understand two markets:
The market for capital.
And the market for customers.
Ultimately, you need both.
— The Startup Khan
Your 5-minute startup edge — funding news, tools, and founder playbooks.
